You just read:

Cell Therapeutics Submits Day 120 Response for Pixantrone Marketing Authorization Application to European Medicines Agency; Potential Q1 2012 Opinion on Approval

News provided by

Cell Therapeutics, Inc.

Aug 23, 2011, 01:30 ET